The Federal Trade Commission on Wednesday accused GoodRx, the prescription drug discount platform, of sharing sensitive personal information about its users’ prescriptions and health conditions with big tech companies.
GoodRx, which also runs a marketplace for telehealth services, agreed to pay a $1.5 million civil penalty for sharing users’ health data — like medication use or health conditions — with third parties including Facebook, Google, and Twilio for advertising. The settlement marks the first time the FTC has taken action under its Health Breach Notification Rule, and comes as the federal government looks to crack down on consumer companies deceptively selling and sharing health data.
GoodRx collects sensitive information from users and from pharmacy benefit managers who confirm when a customer buys a drug using a discount from GoodRx. About 55 million people have used GoodRx since 2017.
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect